Loading
Sudeep Gupta leads India's largest cancer centre and its programme of pragmatic, affordable trials.
Sudeep Gupta is Director of the Tata Memorial Centre in Mumbai, India's largest cancer centre, and Professor of Medical Oncology. A breast and gynaecologic medical oncologist, he leads the centre's programme of pragmatic, affordable trials, randomised studies designed for resource-limited settings that reach tens of thousands of new patients a year. His publications include the randomised trial of locoregional treatment of the primary tumour in metastatic breast cancer and the trial of peritumoral infiltration of local anaesthetic before surgery in early breast cancer. His interests span HR-positive, triple-negative and ovarian cancer, clinical trials and global oncology.
| Title | Journal | Year |
|---|---|---|
| Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial | The Lancet Oncology | 2015 |
| Effect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer | Journal of Clinical Oncology | 2023 |
Shares Burden-matched funding for trials led in low- and middle-income countries, Advanced Centre for Treatment, Research and Education in Cancer, National Cancer Grid of India, Tata Memorial Centre.
Shares Low-dose olanzapine for cancer anorexia (Tata Memorial), Cachexia pharmacotherapy: GDF-15 blockade, anamorelin, olanzapine.
Shares Pivotal trials include sites in Africa, South Asia and Latin America, sponsor-funded, Burden-matched funding for trials led in low- and middle-income countries, HR-positive / HER2-negative breast cancer.
Shares Burden-matched funding for trials led in low- and middle-income countries, Tata Memorial Centre, HR-positive / HER2-negative breast cancer.
Shares Pivotal trials include sites in Africa, South Asia and Latin America, sponsor-funded, HR-positive / HER2-negative breast cancer.
Shares Burden-matched funding for trials led in low- and middle-income countries, Tata Memorial Centre, HR-positive / HER2-negative breast cancer.
Shares National Cancer Grid of India, Tata Memorial Centre, HR-positive / HER2-negative breast cancer.
Shares Low-dose olanzapine for cancer anorexia (Tata Memorial), Tata Memorial Centre.